CYP8B1
Basic information
Region (hg38): 3:42856005-42875898
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP8B1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 23 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 8 | |||||
Total | 0 | 0 | 31 | 3 | 6 |
Variants in CYP8B1
This is a list of pathogenic ClinVar variants found in the CYP8B1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-42864668-A-G | not specified | Uncertain significance (Nov 12, 2021) | ||
3-42864678-T-G | not specified | Uncertain significance (Sep 30, 2021) | ||
3-42865008-G-C | not specified | Uncertain significance (Aug 10, 2021) | ||
3-42865017-C-G | not specified | Uncertain significance (Jun 18, 2021) | ||
3-42865076-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
3-42865244-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
3-42865449-G-T | not specified | Uncertain significance (Dec 21, 2023) | ||
3-42865451-C-T | not specified | Uncertain significance (Dec 21, 2023) | ||
3-42874490-T-C | not specified | Uncertain significance (Jul 05, 2023) | ||
3-42874509-G-T | Likely benign (Jun 01, 2022) | |||
3-42874524-C-T | not specified | Uncertain significance (Dec 21, 2023) | ||
3-42874543-T-A | not specified | Uncertain significance (Apr 26, 2023) | ||
3-42874572-C-T | Likely benign (Jun 01, 2022) | |||
3-42874613-C-T | Benign (Mar 28, 2018) | |||
3-42874628-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
3-42874637-G-A | not specified | Uncertain significance (May 10, 2024) | ||
3-42874643-T-C | not specified | Likely benign (Jun 06, 2023) | ||
3-42874654-A-G | not specified | Uncertain significance (Jun 22, 2021) | ||
3-42874688-G-A | not specified | Uncertain significance (Jun 11, 2021) | ||
3-42874746-G-A | Benign (Apr 04, 2018) | |||
3-42874748-G-A | Benign (Jul 31, 2018) | |||
3-42874753-G-T | not specified | Uncertain significance (Aug 10, 2021) | ||
3-42874772-G-A | not specified | Uncertain significance (Jan 29, 2024) | ||
3-42875019-C-A | Benign (Dec 31, 2019) | |||
3-42875038-T-A | not specified | Uncertain significance (May 18, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYP8B1 | protein_coding | protein_coding | ENST00000316161 | 1 | 20137 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000206 | 0.730 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0712 | 278 | 281 | 0.988 | 0.0000162 | 3297 |
Missense in Polyphen | 111 | 112.64 | 0.9854 | 1378 | ||
Synonymous | 0.546 | 104 | 111 | 0.934 | 0.00000608 | 1006 |
Loss of Function | 1.08 | 9 | 13.2 | 0.681 | 7.13e-7 | 149 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in bile acid synthesis and is responsible for the conversion of 7 alpha-hydroxy-4-cholesten-3-one into 7 alpha, 12 alpha-dihydroxy-4-cholesten-3-one. Responsible for the balance between formation of cholic acid and chenodeoxycholic acid. Has a rather broad substrate specificity including a number of 7-alpha- hydroxylated C27 steroids. {ECO:0000250|UniProtKB:O02766}.;
- Pathway
- Primary bile acid biosynthesis - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);27-Hydroxylase Deficiency;Bile Acid Biosynthesis;Congenital Bile Acid Synthesis Defect Type II;Cerebrotendinous Xanthomatosis (CTX);Zellweger Syndrome;Familial Hypercholanemia (FHCA);Congenital Bile Acid Synthesis Defect Type III;PPAR Alpha Pathway;Farnesoid X Receptor Pathway;Nuclear Receptors Meta-Pathway;Nuclear Receptors in Lipid Metabolism and Toxicity;PPAR signaling pathway;Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;Metabolism of lipids;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Arachidonic acid metabolism;Sterols are 12-hydroxylated by CYP8B1;Endogenous sterols;Eicosanoids;Cytochrome P450 - arranged by substrate type;Biological oxidations;Metabolism;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Synthesis of bile acids and bile salts;Bile acid and bile salt metabolism;Fatty acid metabolism;Nicotinamide salvaging;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of steroids;Metabolism of vitamins and cofactors;Bile acid biosynthesis;bile acid biosynthesis, neutral pathway
(Consensus)
Intolerance Scores
- loftool
- 0.609
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.93
Haploinsufficiency Scores
- pHI
- 0.141
- hipred
- N
- hipred_score
- 0.190
- ghis
- 0.410
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.00289
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cyp8b1
- Phenotype
- homeostasis/metabolism phenotype; digestive/alimentary phenotype; liver/biliary system phenotype;
Gene ontology
- Biological process
- bile acid biosynthetic process;sterol metabolic process;oxidation-reduction process
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane;organelle membrane
- Molecular function
- iron ion binding;sterol 12-alpha-hydroxylase activity;oxygen binding;heme binding;7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity